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PCR amplification and DNA sequencing of the expression locus from Neisseria gonorrhoeae contained in
urine sediments collected from experimentally infected human subjects produced two observations. First,
different pilin sequences were obtained when separate aliquots of the same sample were amplified and
sequenced. In contrast, the same pilin sequence was obtained when repeated amplifications were performed on
individual colonies grown from the clinical samples. Second, mixed sequences (i.e., more than one nucleotide
at variable positions in the pilin gene sequence) were observed in both the direct clinical isolates and individual
cultures grown from the isolates. These results suggest that when clinical samples are directly examined by
PCR amplification and sequencing, multiple amplifications may be required to detect sequence variants in the
sample and minority variant sequences will not always be detected.
PCR with clinical specimens of tissue, hair, blood, and
urine for templates has been used to generate many valuable
diagnostic tests which can screen for the presence of infec-
tious disease agents or the genetic predisposition for many
congenital diseases. Because of the limiting amount of
template in many clinical samples, it is often necessary to
amplify target regions of DNA. Although DNA cloning
procedures can provide a template for genetic studies, they
are time-consuming, and PCR technology has improved the
reliability and efficiency of template amplification for diag-
nostic applications. DNA sequencing has become an impor-
tant tool in biomedical research, providing information about
the molecular basis for many heritable and infectious human
diseases, but a significant amount of purified template is
required for DNA sequence analysis. Once sufficient tem-
plate is isolated, a wide variety of methods that use either
single- or double-stranded templates can be used to deter-
mine the DNA sequence of a gene (3, 6, 7).
Neisseria gonorrhoeae (gonococcus [GC]) is a gram-
negative diplococcus and the causative agent of the sexually
transmitted disease gonorrhea. Pili are filamentous-like
structures emanating from the cell surface of the GC, which
aid in attachment to host epithelial cells (8, 14, 15, 18, 21).
Pili are also highly immunogenic and undergo antigenic
variation to evade the human immune response and to
change the functional properties of the pilus (4, 5, 11, 19, 22,
24). One or two expression loci (pilE) and multiple silent loci
(pilS) exist within the GC chromosome (4, 17). pilE contains
a complete pilin gene that is able to produce pilin monomers
which can be assembled into a pilus, while the multiple,
transcriptionally silent loci are missing the 5' promoter
sequences and conserved coding sequences (4, 16, 19).
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Through homologous recombination (10), variant pilin se-
quences from the silent loci are donated into the expression
locus resulting in antigenic variation (4, 5, 19). We are
studying pilin antigenic variation in N. gonorrhoeae through
a human challenge study which uses strain FA1090 to
produce clinical signs of disease (2, 20). Pilin variation has
been examined in bacteria contained in urine sediments and
from individual colonies grown in vitro from the clinical
samples. PCR amplification of the expression locus from the
GC chromosome allows us to study the changes that occur in
pilin sequences during the colonization and infection of the
male urethra (20). PCR amplification of target DNA and then
cycle sequencing reactions with end-labeled primers have
proven to be reliable and efficient means of performing this
genetic analysis.
The presence of multiple antigenic variants within urine
sediments and urethral swabs collected from the volunteers
has created problemns in analyzing the changes that occur
during infection. We have found that mixed sequences can
be observed when the minority sequence is as little as 33% of
the sample. In addition, when low amounts of amplifiable
template encoding multiple gene sequences are present,
individual amplifications of the same sample can result in the
determination of different gene sequences. Thus, when com-
plex mixtures of variant gene sequences are present in a
clinical sample, multiple amplifications may be required to
fully characterize a mixed gene population.
MATERIALS AND METHODS
Origin and collection of clinical samples. Male volunteers
between the ages of 18 and 35 years were inoculated with
approximately 106 cells taken from 100 to 200 colonies of a
piliated variant of strain FA1090 by using a pediatric catheter
inserted 5 cm into the urethra (2). At 2 h postinoculation,
urine samples were collected, and from then on, urine and
genital swab samples were taken at three time points daily.
In addition to urine sediments, single colony isolates were
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FIG. 1. PCR amplification and cycle sequencing of the pilin expression locus. (A) Schematic depiction of the pilin expression locus of N.
gonorrhoeae. Listed above the drawing are the minicassettes (minicassettes [mcl 2 to 6; the 3' minicassette 1 is not labeled) which are
proposed regions of variability within the expression locus (4). The numbers above the drawing indicate the amino acid residue number. The
black boxes are conserved regions, and the white boxes are variable regions of the expression locus. (B) Amplification of the pilin expression
locus out of the GC chromosome. The dotted lines depict the product generated by PCR amplification. Primers are indicated by number, and
the 5' to 3' orientation is indicated by a thin arrow. Primer 1 is PILSTART, and primer 2 is SP3A; these primers were used in the first PCRs
of all samples (Table 1). Primer 3 is PILRBS, and primer 4 is SMACLA1; these primers were used for the nested amplification from the clinical
samples (Table 1). (C) Sequencing strategy for the variable portions of the expression locus in GC. The numbers indicate the different primers
used for the cycle sequencing reactions, and the thin arrows indicate their direction. The bold arrows show the approximate region of the
expression locus,which was sequenced by each primer. Primer 5 is CONSTF2, primer 6 is CYS1R, primer 7 is CYS1F, and primer 8 is
PILEND (Table 1).
passaged twice in vitro at 37°C with 5% CO2 on GCB
medium (Difco, Detroit, Mich.) with Kellogg supplements
(9) and VCN inhibitor (BBL, Cockeysville, Md.) before
freezing. All volunteers were treated with ceftriaxone at the
onset of clinical signs (purulent exudate) or at 5 days
postinoculation. All samples were stored at -80°C in 3%
Trypticase soy broth and 25% glycerol.
PCR amplification of DNA templates for sequencing. In
order to prepare template for PCR amplification, 5 ,ul of
thawed gonococcal samples were mixed with 5 ,ul of colony
lysis buffer containing 1% Triton X-100, 2 mM EDTA, and
20 mM Tris (pH 8.5). Template-lysis mixtures were then
vortexed for 1 min, heated at 94°C for 15 min, vortexed again
for 1 min, and used as templates for the PCR.
Because of the lower amounts of bacteria present in the
clinical samples, nested PCR was used to amplifypilE out of
the bacterial chromosome (Fig. 1). When frozen stocks of
isolated colonies were used as templates, only single PCR
amplifications were necessary to produce an adequate
amount of template for sequencing. However, nested PCR
from these samples provided identical sequence information
as single amplification. The primers used in PCR are listed in
Table 1.
All amplifications were done in 100-,ul volumes containing
50 pmol of each primer, 0.2 mM (each) deoxynucleoside
triphosphates (Promega, Madison, Wis.), 50 mM KCl, 10
mM Tris-HCl, 0.1% Triton X-100, 3 mM MgCl2, and 2 U of
Taq DNA polymerase (Promega). Evaporation of the reac-
tion mixture was prevented by using paraffin beads (25). The
thermocycling profile used for the outer primer pair was 30
cycles of 94°C for 1 min, 60°C for 1 min, and 72°C for 2 min,
producing a product of approximately 780 bp (PTC-100, MJ
Research, Watertown, Mass.). The thermocycling profile
used for the internal primer pair was 30 cycles of 94°C for 1
min, 55°C for 1 min, and 72°C for 2 min, producing a product
of approximately 630 bp.
DNA sequence analysis. Prior to sequencing, the entire
PCR amplification mixture was passed through a Sepharose
TABLE 1. Oligonucleotides used for PCR and sequencing strategy
Primer DNA sequencea Description
PILSTART GAGATAAACGCATAAAATTTCACC Sequence in 5' conserved promoter region ofpilEl used with SP3A
SP3A CCGGAACGGACGACCCCG Sequence in 3' conserved untranslated region of all pil loci
PILRBS GGCTTTCCCCTTTCAATTAGGAG Sequence at ribosome-binding site ofpilE used with SMACLA1
SMACLA1 CAAACCCTTAAAAGACAGC Sequence in 3' untranslated region of allpil loci
CONSTF2 TACCAAGACTACACCGCCCG Sequence in 5' conserved region of all pil loci used for sequencing
CYSlR GTCCGCAGAACCATTTTACCG Sequence in conserved cysl region of all pil loci used for sequencing
CYSlF CGGTAAAATGGTTCTGCGGAC Inverse complement of CYSlR used for sequencing
PILEND CGCTTGATTTATTTAAAATTTAAGG Sequence in 3' untranslated region of some pil loci used for sequencing
a All DNA sequences are listed 5' to 3'.
VOL. 32, 1994
466 WRIGHT ET AL.
CL-6B (Sigma, St. Louis, Mo.) spin column containing 15
times the sample volume of a 60% slurry of resin in TE (10
mM Tris [pH 8.0], 1 mM EDTA). This removed both
residual oligonucleotide primers and buffer components
from the PCR amplification mixture. Approximately 10 to 50
ng of amplified template from the spin-dialyzed PCR mixture
was then used for sequencing by using [y-32P]ATP-end-
labeled primers and the finole DNA Sequencing System
(Promega). The end-labeled primers corresponded to con-
served regions within the pilE and generated complete
double-stranded sequence data for the variable portions of
each pilin gene (Table 1 and Fig. 1). The thermocycling
profile used with these primers was initial denaturation at
95°C for 2 min and then 30 cycles of 95°C for 30 s, 60°C for
30 s, and 70°C for 1 min. The samples were heated at 75°C for
2 min and run on a 5% Long Ranger denaturing gel (J. T.
Baker, Phillipsburg, N.J.) at 60 W, dried at 80°C for 40 min,
and exposed to X-OMAT-AR film (Kodak, Rochester, N.Y.)
overnight.
Sequencing of mixed templates. Purified PCR products of
two different pilin variants were diluted, and their concen-
trations were equalized by matching band intensities on
ethidium bromide-stained agarose gels. These two templates
were then mixed at the following ratios: 1:1, 2:1, 4:1, and
8:1. One template was kept at 10 ng, and the concentration of
the other template was varied by diluting at twofold incre-
ments, from 10 to 1.25 ng. Once the templates were com-
bined, the mixture was used as the starting template for
sequencing reactions following the protocol described
above. To analyze mixed sequences after PCR amplification,
serial dilutions of the two starting templates were analyzed
by PCR with the nested primers until the minimal concen-
tration that produced a visible product on an ethidium
bromide-stained agarose gel was found. Approximately 1.6
pg of starting template was consistently able to produce a
visible PCR product. One template was used at 1.6 pg, and
the other template was diluted at twofold increments from
1.6 to 0.2 pg. Templates were then mixed at ratios of 1:1, 1:2,
1:4, and 1:8 and amplified by PCR; this was followed by
DNA sequencing.
RESULTS AND DISCUSSION
During our studies of gonococcal pilin variation, we
collected urine sediments containing various numbers of
viable bacteria (Table 2). In addition, bacteria were isolated
from genital swab specimens from the time that clinical signs
appeared. The pilE locus of the bacteria was amplified by
PCR by using either nested or single rounds of PCR. The
resultant PCR products were then sequenced by using the
finole DNA Sequencing kit (Promega) and four oligonucleo-
tides that produced the DNA sequence of both strands of the
variable gene sequences.
Prior to these studies, the number of different variant gene
sequences that could be expressed at any one time during
infection was unknown. We assumed that for any one
sample one or two predominant sequences would be ex-
pressed in the population. Our initial observations showed
that when amplification was done from the urine sediments,
one or two pilin variant sequences were observed. However,
when we returned to an identical urine sample and reampli-
fied it to create a new sequencing template, gene sequences
different from those found originally were observed (Table
2). Therefore, it appears that the urine sediments contain
mixed populations of bacteria expressing different pilin
genes. The initial uniform gene sequences gained from the
TABLE 2. Number of sequences generated from repeated





Inoculuma > 106 3 1
1-81-S2b > 106 2 1
Clinical samples
1-2-BU 1.9 x 103/ml 3 3
1-57-BU 1.6 x 102/ml 2 2
2-2-BU 4.7 x 102/ml 2 2
a The FA1090 inoculum was the sample used to initiate infection in the
volunteers (20).
b The numbering system for the rest of the samples may be read as follows:
the first number indicates the volunteer from whom the sample was collected,
the second number indicates the time postinoculation (in hours) that the
sample was collected, B indicates a direct clinical specimen, U indicates a
urine sample, and S indicates a sample from a genital swab.
urine samples presumably represent one or two variant
genes in the population that were amplified early in the
nested PCRs. The different sequences found were not a
result of errors produced by the Taq polymerase since the
changes occurred only in variable positions of the pilin gene
(20). Additionally, the number of differences was much
greater than that which could be produced by polymerase
misincorporation (20). Thus, each time the sample was used
to produce a new template, a new member of the population
was amplified early and produced a different sequence.
Multiple amplifications and sequencing reactions may be
required to obtain a better representation of the population
present within any mixed clinical sample.
In addition to the problem of clinical samples yielding
different sequence information upon reamplification, se-
quences were also mixed because of the presence of two or
more variant templates that contributed to the sequence
information. To determine the percentage of the total tem-
plate at which a particular pilin variant must be present to
provide mixed sequences, we performed template mixing
experiments. Low levels of two different templates were
equalized on an ethidium bromide-stained agarose gel and
were then mixed at ratios of 1:1, 2:1, 4:1, and 8:1. The mixed
templates were then used for cycle sequencing reactions; the
minority sequence became visible at template ratios of 4:1
(Fig. 2B). In other words, the template producing the sec-
ondary sequence must be present at levels of 20% of the total
template or greater in order to produce a visible band on the
autoradiogram. However, it was not until the 2:1 ratio (33%
of total template) that the secondary sequence began to rise
to levels above what we would consider normal background
levels (Fig. 2B). Template mixing prior to PCR amplification
was done in two ways, keeping one template constant and
diluting the other template. Both mixing experiments pro-
duced similar results. When the different templates were
diluted to the minimal level that produced a detectable
amplification product and were mixed prior to both PCR
amplification and DNA sequencing, the secondary sequence
was again observable at the 1:4 ratio of template mixing and
above background levels at the 1:2 ratio (Fig. 2A). Second-
ary sequences resulting from template mixing prior to PCR
amplification were less intense than those resulting from
template mixing and then direct sequence analysis. Similar
results from template mixing experiments were seen by
J. CLIN. MICROBIOL.
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FIG. 2. Template mixing and its effect on PCR amplification and
DNA sequencing. (A) Templates were mixed at the ratios listed
above the panel, with template B at 1.6 pg and template A at twofold
dilutions from 1.6 to 0.2 pg. Points of sequence variation between
the two genes are indicated on the right. Mixed templates were used
for PCR amplification and then DNA sequencing, generating the
data shown. (B) By using the same stock of template as was used in
panel A, template A remained at 10 ng and template B was diluted
at twofold dilutions from 10 to 1.25 ng. Mixed templates were
sequenced directly, and points of sequence variation are indicated
on the right.
Leitner et al. (12), who used solid-phase purification of
single-stranded template and fluorescence-based automated
sequencing. Detection of secondary sequences in this sys-
tem was more sensitive, with 10 to 25% of total template
being detectable (12).
When PCR amplification is used to produce sequencing
template from a uniform source, a pure culture, or a cell line,
the possibility of mixed sequences being present is remote.
Alternatively, when clinical or environmental samples are
used to generate sequencing templates, it is often possible
that more than one gene sequence is present in the sample.
The gonococcal pilin gene is unusual in that it is highly
variable, with multiple sequence variants possible in a single
strain. The observations reported here would also relate to
sequence analysis of other variable genes such as Borrelia
variable major proteins (1), Trypanosoma variable surface
glycoproteins (13), or rabbit or chicken immunoglobulin
genes (23). In addition, mixed populations of different strains
of a microorganism would create a similar situation when
more than one version of a gene sequence was present.
These observations may also be pertinent when a gene
family is studied in a clonal cell population. Our data show
that if single amplifications are performed, only one of the
gene sequences might be recorded and others might be
missed. Therefore, in order to obtain an accurate represen-
tation of variant gene sequences expressed in populations,
multiple PCR and sequence analyses may be required. While
this type of selective amplification is an important factor
when samples are sequenced directly, it could also occur
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